TY - JOUR
T1 - Challenging the Ischemic Core Concept in Acute Ischemic Stroke Imaging
AU - Goyal, Mayank
AU - Ospel, Johanna M.
AU - Menon, Bijoy
AU - Almekhlafi, Mohammed
AU - Jayaraman, Mahesh
AU - Fiehler, Jens
AU - Psychogios, Marios
AU - Chapot, Rene
AU - Van Der Lugt, Aad
AU - Liu, Jianmin
AU - Yang, Pengfei
AU - Agid, Ronit
AU - Hacke, Werner
AU - Walker, Melanie
AU - Fischer, Urs
AU - Asdaghi, Negar
AU - McTaggart, Ryan
AU - Srivastava, Padma
AU - Nogueira, Raul G.
AU - Moret, Jacques
AU - Saver, Jeffrey L.
AU - Hill, Michael D.
AU - Dippel, Diederik
AU - Fisher, Marc
N1 - Publisher Copyright:
© 2020 Lippincott Williams and Wilkins. All rights reserved.
PY - 2020/10/1
Y1 - 2020/10/1
N2 - Endovascular treatment is a highly effective therapy for acute ischemic stroke due to large vessel occlusion and has recently revolutionized stroke care. Oftentimes, ischemic core extent on baseline imaging is used to determine endovascular treatment-eligibility. There are, however, 3 fundamental issues with the core concept: First, computed tomography and magnetic resonance imaging, which are mostly used in the acute stroke setting, are not able to precisely determine whether and to what extent brain tissue is infarcted (core) or still viable, due to variability in tissue vulnerability, the phenomenon of selective neuronal loss and lack of a reliable gold standard. Second, treatment decision-making in acute stroke is multifactorial, and as such, the relative importance of single variables, including imaging factors, is reduced. Third, there are often discrepancies between core volume and clinical outcome. This review will address the uncertainty in terminology and proposes a direction towards more clarity. This theoretical exercise needs empirical data that clarify the definitions further and prove its value.
AB - Endovascular treatment is a highly effective therapy for acute ischemic stroke due to large vessel occlusion and has recently revolutionized stroke care. Oftentimes, ischemic core extent on baseline imaging is used to determine endovascular treatment-eligibility. There are, however, 3 fundamental issues with the core concept: First, computed tomography and magnetic resonance imaging, which are mostly used in the acute stroke setting, are not able to precisely determine whether and to what extent brain tissue is infarcted (core) or still viable, due to variability in tissue vulnerability, the phenomenon of selective neuronal loss and lack of a reliable gold standard. Second, treatment decision-making in acute stroke is multifactorial, and as such, the relative importance of single variables, including imaging factors, is reduced. Third, there are often discrepancies between core volume and clinical outcome. This review will address the uncertainty in terminology and proposes a direction towards more clarity. This theoretical exercise needs empirical data that clarify the definitions further and prove its value.
KW - computed tomography
KW - magnetic resonance imaging
KW - thrombectomy
UR - https://www.scopus.com/pages/publications/85092119687
U2 - 10.1161/STROKEAHA.120.030620
DO - 10.1161/STROKEAHA.120.030620
M3 - Artículo de revisión
C2 - 32933417
AN - SCOPUS:85092119687
SN - 0039-2499
VL - 51
SP - 3147
EP - 3155
JO - Stroke
JF - Stroke
IS - 10
ER -